Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07308717 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Name: Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol — clinical trial record (NCT07308717)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorMemorial Sloan Kettering Cancer Center

Started2025-12-16

View on ClinicalTrials.gov ↗

Memorial Sloan Kettering Cancer Center

779 trials monitored

See 100 trials at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Trial Details

NCT Number	NCT07308717
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Breast Cancer
Enrollment	1,896 participants
Start Date	2025-12-16
Primary Completion	2027-12-16 (estimated)
Study Completion	2027-12-16 (estimated)
Updated on ClinicalTrials.gov	2025-12-30